DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Schmid P, Adams S, Rugo HS. et al.
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer.
N Engl J Med 2018;
379: 2108-2121
doi:10.1056/NEJMoa1809615
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.